Literature DB >> 24436534

Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors.

Thomas J Vogl1, Mohammad Shafinaderi1, Stefan Zangos1, Sebastian Lindemayr1, Khashayar Vatankhah1.   

Abstract

Standard treatment options in patients with lung cancer and pulmonary metastases are surgery, radiotherapy, chemotherapy, and immunotherapy. For reducing clinical complications of surgery and achieving a better local response, transpulmonary chemoembolization of the lungs is a possible interventional technique in which anticancer drugs are administered directly into a tumor through its feeding vessels followed by occlusive agents that are injected through the delivery catheter for blocking the vessel. This allows a longer contact period in the tumor with a higher cytostatic drug concentration. The technique is safe and results present promising local response rates, but the influence on survival is still questionable. This article describes the current role of intravascular therapies in the treatment of pulmonary malignancies.

Entities:  

Keywords:  bronchial artery infusion; interventional radiology; isolated lung perfusion; lung suffusion; primary lung malignancy; secondary lung malignancy; transpulmonary chemoembolization (TPCE)

Year:  2013        PMID: 24436534      PMCID: PMC3709942          DOI: 10.1055/s-0033-1342959

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  47 in total

1.  Chemoembolization of the lung improves tumor control in a rat model.

Authors:  Paul Schneider; Stefanie Kampfer; Christoph Loddenkemper; Thomas Foitzik; Heinz J Buhr
Journal:  Clin Cancer Res       Date:  2002-07       Impact factor: 12.531

2.  Selective bronchial arteriography and intra-arterial chemotherapy in carcinoma of the lung.

Authors:  P C Kahn; R E Paul; H F Rheinlander
Journal:  J Thorac Cardiovasc Surg       Date:  1965-11       Impact factor: 5.209

3.  [Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases].

Authors:  G Friedel; U Pastorino; M Buyse; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam; H Toomes
Journal:  Zentralbl Chir       Date:  1999       Impact factor: 0.942

Review 4.  For the clinical application of thermochemotherapy given at mild temperatures.

Authors:  M Urano; M Kuroda; Y Nishimura
Journal:  Int J Hyperthermia       Date:  1999 Mar-Apr       Impact factor: 3.914

5.  [Evaluation of bronchial arterial infusion (BAI) for high risk lung cancer].

Authors:  H Koshiishi; K Utsumi; F Tamamoto; E Takahashi
Journal:  Gan To Kagaku Ryoho       Date:  2000-10

6.  Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas.

Authors:  G B Ratto; S Toma; D Civalleri; G C Passerone; M Esposito; D Zaccheo; M Canepa; P Romano; R Palumbo; F De Cian; F Scarano; M Vannozzi; E Spessa; G Fantino
Journal:  J Thorac Cardiovasc Surg       Date:  1996-09       Impact factor: 5.209

7.  [Clinical observation on treatment of non-small cell lung cancer with Chinese herbal medicine combined with bronchial arterial infusion chemotherapy].

Authors:  C L Liu; Y D Wang; X J Jin
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2001-08

8.  Double blood supply of bronchogenic carcinoma from multiple arteries.

Authors:  C Hellekant; K Jonsson
Journal:  Acta Radiol Diagn (Stockh)       Date:  1981

9.  Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection.

Authors:  B Weksler; B Ng; J T Lenert; M E Burt
Journal:  Ann Thorac Surg       Date:  1993-08       Impact factor: 4.330

10.  [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].

Authors:  W Wagner; M von Eiff; F Klinke; O Micke; C Rübe; N Willich
Journal:  Strahlenther Onkol       Date:  1995-07       Impact factor: 3.621

View more
  6 in total

1.  An applied anatomical study of bronchial artery.

Authors:  Qing-Lin Fei; Yuan-Yuan Zhou; Yi-Xiao Yuan; Shan-Quan Sun
Journal:  Surg Radiol Anat       Date:  2017-09-23       Impact factor: 1.246

2.  Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer.

Authors:  Huiwei Qi; Sen Jiang; Dong Yu; Huijuan Ni; Qiong Hu; Jie Zhang
Journal:  Med Oncol       Date:  2015-10-23       Impact factor: 3.064

3.  Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.

Authors:  Xiaofei Liu; Hu Lin; Qin Wang; Mi Mu; Pan Pan; Fangfang Tian; Rui Zhang; Weiguo Zhao; Pengtao Bao
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

4.  Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity.

Authors:  Mahasweta Das; Mark Howell; Elspeth A Foran; Rohit Iyre; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Cell Transplant       Date:  2017-10       Impact factor: 4.064

5.  Time to get started with endobronchial microwave ablation-chances, pitfalls and limits for interventional pulmonologists.

Authors:  Wolfgang Hohenforst-Schmidt; Pavlos Zarogoulidis
Journal:  Transl Lung Cancer Res       Date:  2020-04

6.  Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: a pilot study.

Authors:  Zhongwei Zhao; Jianfei Tu; Xiaoxi Fan; Jingjing Song; Fazong Wu; Xihui Ying; Jianting Mao; Jiansong Ji
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.